INTERNATIONAL PATENT: DELFI DIAGNOSTICS, INC. FILES APPLICATION FOR "CANCER DIAGNOSIS AND TREATMENT RESPONSE SCREENING WITH FRAGMENTOMICS AND METHYLATION ANALYSIS"

GENEVA, March 31 -- DELFI DIAGNOSTICS, INC. (2809 Boston Street, Suite 503Baltimore, Maryland 21224) filed a patent application (PCT/US2025/047392) for "CANCER DIAGNOSIS AND TREATMENT RESPONSE SCREENING WITH FRAGMENTOMICS AND METHYLATION ANALYSIS" on Sep 22, 2025. With publication no. WO/2026/064729, the details related to the patent application was published on Mar 26, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): GERSHMAN, Ariel (2809 Boston Street, Suite 503Baltimore, Maryland 21224)

Abstract: Disclosed herein are methods of determining a cell free DNA (cfDNA) methylation profile and a...